Acute graft-versus-host disease (GVHD) is a common immune complication that can occur
after allogeneic haematopoietic cell transplantation (alloHCT). Acute GVHD is a major …

Although the majority of patients with acute myeloid leukemia (AML) treated with intensive
chemotherapy achieve a complete remission (CR), many are destined to relapse if treated …

The success of reduced intensity conditioning (RIC) transplantation is largely dependent on
alloimmune effects. It is critical to determine whether immune modulation with anti–T-cell …

Abstract The Dutch-Belgian Hemato-Oncology Cooperative Group and the Swiss Group for
Clinical Cancer Research (HOVON-SAKK) collaborative study group evaluated outcome of …

Because information on management and outcome of AML relapse after allogeneic
hematopoietic stem cell transplantation (HSCT) with reduced intensity conditioning (RIC) is …

Stem cell transplantation is used widely in the management of a range of diseases of the
hemopoietic system. Patients are immunosuppressed profoundly in the early posttransplant …

It is unknown whether the severity, timing, and quality of graft-versus-host disease (GVHD)
may be different after nonmyeloablative as compared with myeloablative hematopoietic …

A sequential regimen of chemotherapy, reduced-intensity conditioning (RIC) for allogeneic
stem cell transplantation (SCT), and prophylactic donor lymphocyte transfusion (pDLT) was …

Purpose Retrospective studies have shown similar survival among patients with acute
myeloid leukemia (AML) and myelodysplasia (MDS) after nonmyeloablative compared with …

We evaluated the efficacy of umbilical cord blood (UCB) in the setting of a nonmyeloablative
regimen consisting of fludarabine (200 mg/m2), cyclophosphamide (50 mg/kg), and a single …